Inactivation of hantaan virus-containing samples for subsequent investigations outside biosafety level 3 facilities

被引:37
作者
Kraus, AA [1 ]
Priemer, C [1 ]
Heider, H [1 ]
Krüger, DH [1 ]
Ulrich, R [1 ]
机构
[1] Univ Med Berlin, Inst Virol, Charite, DE-10117 Berlin, Germany
关键词
biosafety laboratory; cell culture; hantavirus; virus inactivation;
D O I
10.1159/000084603
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Objectives: The potential risk of accidental infection by hantaviruses in a clinical or research laboratory necessitates special precautionary measures. A biosafety program must address handling and disposal of infectious materials as well as appropriate virus inactivation or depletion procedures to permit necessary further processing of specimens outside the biosafety level 3 laboratory. Methods: To study the elimination of hantavirus infectivity, the effects of different chemical and physical inactivation and depletion procedures were investigated on Hantaan virus- containing materials. An infectivity assay for hantaviruses was utilised to verify these procedures which are commonly preceding investigations such as ELISA, flow cytometry analysis, Western blot or immunofluorescence assay. Results: Chemical inactivation with methanol, paraformaldehyde, acetone/methanol and detergent-containing lysis buffer as well as physical forces such as UV irradiation and filtration efficiently reduced viral infectivity in infected cells and their supernatants below the detection limit. Conclusion: The virus inactivation and depletion methods described herein are suitable to prepare non-infectious samples for further use in immunological, virological and cell-biological assays. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:255 / 261
页数:7
相关论文
共 21 条
[11]   BANK VOLE MONOCLONAL-ANTIBODIES AGAINST PUUMALA VIRUS ENVELOPE GLYCOPROTEINS - IDENTIFICATION OF EPITOPES INVOLVED IN NEUTRALIZATION [J].
LUNDKVIST, A ;
NIKLASSON, B .
ARCHIVES OF VIROLOGY, 1992, 126 (1-4) :93-105
[12]   Hantaviruses: Immunology, treatment, and prevention [J].
Maes, P ;
Clement, J ;
Gavrilovskaya, I ;
Van Ranst, M .
VIRAL IMMUNOLOGY, 2004, 17 (04) :481-497
[13]   Inactivation of West Nile virus during serologic testing and transport [J].
Mayo, DR ;
Beckwith, WH .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (08) :3044-3046
[14]   Infectivity of RNA from inactivated poliovirus [J].
Nuanualsuwan, S ;
Cliver, DO .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2003, 69 (03) :1629-1632
[15]   Hantavirus Pulmonary Syndrome outbreak in Argentina:: Molecular evidence for person-to-person transmission of Andes virus [J].
Padula, PJ ;
Edelstein, A ;
Miguel, SDL ;
López, NM ;
Rossi, CM ;
Rabinovich, RD .
VIROLOGY, 1998, 241 (02) :323-330
[16]   Hantavirus infection of dendritic cells [J].
Raftery, MJ ;
Kraus, AA ;
Ulrich, R ;
Krüger, DH ;
Schönrich, G .
JOURNAL OF VIROLOGY, 2002, 76 (21) :10724-10733
[17]   Hantaviruses: A global disease problem [J].
Schmaljohn, C ;
Hjelle, B .
EMERGING INFECTIOUS DISEASES, 1997, 3 (02) :95-104
[18]   Genetic characterisation of a hantavirus isolated from a laboratory-acquired infection [J].
Shi, XH ;
McCaughey, C ;
Elliott, RM .
JOURNAL OF MEDICAL VIROLOGY, 2003, 71 (01) :105-109
[19]   Emerging viruses:: The case 'hantavirus' [J].
Ulrich, R ;
Hjelle, B ;
Pitra, C ;
Krüger, DH .
INTERVIROLOGY, 2002, 45 (4-6) :318-327
[20]   Human memory cytotoxic T-Lymphocyte (CTL) responses to hantaan virus infection:: Identification of virus-specific and cross-reactive CD8+ CTL epitopes on nucleocapsid protein [J].
Van Epps, HL ;
Schmaljohn, CS ;
Ennis, FA .
JOURNAL OF VIROLOGY, 1999, 73 (07) :5301-5308